Skip to main content

ADVERTISEMENT

Rigved V. Tadwalkar, MD, MS

10/27/2014
Cardiac allograft vasculopathy (CAV) is an immunologically-mediated phenomenon that occurs in up to 50% of patients surviving to 10 years post orthotopic heart transplant. While the pediatric subgroup of OHT recipients has a lower overall...
Cardiac allograft vasculopathy (CAV) is an immunologically-mediated phenomenon that occurs in up to 50% of patients surviving to 10 years post orthotopic heart transplant. While the pediatric subgroup of OHT recipients has a lower overall...
Cardiac allograft vasculopathy...
10/27/2014
Journal of Invasive Cardiology
10/03/2015
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of...
10/03/2015
Vascular Disease Management